Literature DB >> 8052822

Nasal administration of immunoglobulin as effective prophylaxis against infections in elite cross-country skiers.

P Hemmingsson1, L Hammarström.   

Abstract

15 elite skiers (Swedish olympic team) taking part in the games in Alberville were prophylactically treated with nasal administration of immunoglobulin, mainly IgA. Team coaches served as controls. No infections occurred in the treated group, whereas 9/19 of the coaches developed symptoms of infection. These results suggest that nasal administration of antibodies significantly reduces the incidence of upper respiratory tract infections in elite skiers and may serve as a valuable short-term physiological prophylaxis in the prevention of disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8052822     DOI: 10.3109/00365549309008580

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  5 in total

Review 1.  Intranasal antibody prophylaxis for protection against viral disease.

Authors:  R Weltzin; T P Monath
Journal:  Clin Microbiol Rev       Date:  1999-07       Impact factor: 26.132

2.  Lack of effect of orally administered human serum immunoglobulin on the normal human oral and intestinal microflora.

Authors:  A K Bogstedt; C E Nord; L Hammarström
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-01       Impact factor: 3.267

3.  Successful Treatment of Sinusitis with Topical Human Milk in a Lymphoma Patient Using Rituximab.

Authors:  Nise Yamaguchi; Patricia Palmeira; Magda Carneiro-Sampaio
Journal:  J Clin Immunol       Date:  2019-04-06       Impact factor: 8.317

4.  Egg-Derived Anti-SARS-CoV-2 Immunoglobulin Y (IgY) With Broad Variant Activity as Intranasal Prophylaxis Against COVID-19.

Authors:  Lyn R Frumkin; Michaela Lucas; Curtis L Scribner; Nastassja Ortega-Heinly; Jayden Rogers; Gang Yin; Trevor J Hallam; Alice Yam; Kristin Bedard; Rebecca Begley; Courtney A Cohen; Catherine V Badger; Shawn A Abbasi; John M Dye; Brian McMillan; Michael Wallach; Traci L Bricker; Astha Joshi; Adrianus C M Boon; Suman Pokhrel; Benjamin R Kraemer; Lucia Lee; Stephen Kargotich; Mahima Agochiya; Tom St John; Daria Mochly-Rosen
Journal:  Front Immunol       Date:  2022-06-01       Impact factor: 8.786

Review 5.  Immunoglobulin Y for Potential Diagnostic and Therapeutic Applications in Infectious Diseases.

Authors:  Lucia Lee; Kate Samardzic; Michael Wallach; Lyn R Frumkin; Daria Mochly-Rosen
Journal:  Front Immunol       Date:  2021-06-09       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.